Association of Monocyte-to-HDL Cholesterol Ratio with Cardiac Syndrome X is Linked to Systemic Infl ammation
Bu çalışmanın amacı, kardiyak sendrom X (KSX) hastalarında monositin HDL kolesterole oranı (MHO)'nı ve kolay kullanılabilir infl amatuvar göstericileri araştırmaktırHastalar ve Yöntem: Çalışmaya 50'si KSX ve 50'si normal koroner arterlere sahip toplam 100 hasta dahil edilmiştir. Bulgular: Total beyaz küre sayısı, nötrofi l sayısı, monosit sayısı, lenfosit sayısı, nötrofi l/lenfosit oranı, C-reaktif protein, hsCRP ve MHO KSX grubunda artmıştır (p< 0.05), ancak HDL kolesterol CSX hastalarında kontrol grubuna göre azalmıştır (p< 0.05). Korelasyon analizinde MHO'nun hsCRP (r= 0.375, p< 0.001) ve CRP (r= 0.403, p< 0.001) ile pozitif yönde korelasyon olduğu gösterilmiştir. Multivariate logistic regresyon analizinde MHO'nun KSX hastalığını göstermede bağımsız bir gösterge olduğu bulundu [odds ratio: 1.250, 95% confi dence interval (CI): 1.240-1.461, p< 0.001]. Sınır değeri 90.6 alırsak, MHO bu oran ile KSX hastalığının varlığını %78 duyarlılık ve %70 özgüllükle göstermektedir. Sonuç: Çalışmamızda MHO KSX hastalarını göstermede ciddi ve bağımsız bir gösterge olduğu gösterilmiştir.
Monositin HDL Kolesterole Oranının Kardiyak Sendrom X ve Sistemik İnfl amasyon ile İlişkisi
The aim of this study was to investigate an easily available infl ammatory marker and monocyteto-high-density lipoprotein cholesterol ratio (MHR) in patients with cardiac syndrome X (CSX)Patients and Methods: The study population included 100 patients of which 50 had CSX (CSX group) and 50 had normal coronary angiograms (control group). Results: Total white blood cell (WBC) count, monocyte count, neutrophil count, NLR, high-sensitivity C-reactive protein (hs-CRP), C-reactive protein (CRP) and MHR were higher in the CSX group (p< 0.05), whereas high-density lipoprotein cholesterol (HDL-C) level was signifi cantly lower in the CSX group as compared with that in the control group (p< 0.05). In the correlation analysis, MHR revealed a signifi cantly positive correlation with hs-CRP (r= 0.375, p< 0.001) and CRP (r= 0.403, p< 0.001). In the multivariate logistic regression analysis, MHR was independently associated with the presence of CSX (odds ratio: 1.250, 95% confi dence interval [CI]: 1.240-1.461, p< 0.001). Using a cut-off level of 90.6, pre-procedural MHR predicted the presence of slow coronary fl ow (SCF) with a sensitivity of 78% and specifi city of 70%. Conclusion: In conclusion, our fi ndings revealed that higher MHR levels were signifi cantly and independently associated with the presence of CSX.
___
- Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole- Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
- Scholz M, Wegener K, Unverdorben M, Kleipzig H. Long-term outcome in patients with angina-like chest pain and normal coronary angiograms [in German]. Herz 2003; 28:413-20.
- Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004; 109:2518-23.
- Al Suwaıd J, Hıgano ST, Holmes Dr JR, Lerman A. Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal fi ndings on angiography. Mayo Clin Proc 2001;76:813-22.
- Hurst T, Olson TH, Olson LE, Appleton CP. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med 2006;119:560-6.
- Luo C, Li Y, Liu D, Hu C, Du Z. The association of brachial fl ow-mediated dilatation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina. Exp Clin Cardiol 2012;17:197-201.
- Recio-Mayoral A, Rimoldi OE, Camci PG, Kaski JC. Infl ammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging 2013;6:660-7.
- Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1- expressing endothelial cells. J Leukoc Biol 2006;80:1156e1164.
- Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213e229.
- Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 2000;73:231e236.
- Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014;46:1619e1625.
- Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Çay S, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fi brillation recurrence after cryoballoon-based catheter ablation. Europace 2015;pii:euu291.
- Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary fl ow is linked to systemic infl ammation. Clin Appl Thromb Hemost 2015; pii: 1076029615594002.
- Karataş MB, Çanga Y, Özcan KS, İpek G, Güngör B, Onuk T, et al. Monocyte to high-density lipoprotein ratio as a newprognosticmarker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Emerg Med 2015 Oct 27. pii: S0735-6757(15)00939-0. doi: 10.1016/j.ajem.2015.10.049
- Demirkol S, Balta S, Unlu M, Arslan Z, Cakar M, Kucuk U, et al. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 2014; 20:250-5.
- Tenekecıoğlu E, Yılmaz M, Demır S, Bekler A, Ozluk OA, Aydın U, et al. Lower hdl-cholesterol is associated with systemic infl ammation in cardiac syndrome X. Minerva Med 2014 Jul 16.
- Ghattas A, Griffi ths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-51.
- Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology 2012;217:476- 82.
- Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti infl ammatory effects of high density lipoproteins. Curr Med Chem 2009;16:667-75.
- Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of infl ammation. Clin Exp Pharmacol Physiol 2010;37:710-8.
- Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial, cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-94.
- Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, et al. High density lipoprotein reduces the human monocyte infl ammatory response. Arterioscler Thromb Vasc Biol 2008;28:2071-7.
- Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-82.
- Kundi H, Gok M, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol 2015;116:1685-9. doi: 10.1016/j.amjcard.2015.08.036